Premenstrual Syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Intervention group: Vitamin C (ascorbic acid), 500 mg, one daily from the 21st day of menstruation to the 5th day of the next cycle for two consecutive months, made in the Faculty of P
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Students must live in the dormitory Students should be willing to participate in the study Students must be single Students must be between 18-40 years old Students should have a normal BMI (18/5-24/9) Students must have regular menstruation (cycle duration 24-38 days) Students' menstrual cycle should be 4-8 days Premenstrual syndrome should be confirmed through a questionnaire derived from DSM V and a daily symptom record form for two consecutive months Students should not use tobacco, alcohol and addictive substances
Exclusion criteria
Exclusion criteria: Students should not suffer from physical diseases such as diabetes, anemia, hypothyroidism, malnutrition, Cushing's syndrome, hyperprolactinemia Students do not have a known mental illness Students should not use anti-depressant drugs, hormones, vitamins, herbal drugs, aspirin and warfarin, drugs related to thyroid disorders, drugs related to prolactin disorders in the last three months Surgery has not been done in the last six months Unfortunate incidents such as the death of relatives have not occurred in the last six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of premenstrual syndrome. Timepoint: The beginning of the study, 2 and 4 after the start of the study. Method of measurement: Questionnaire for temporary diagnosis of premenstrual syndrome and questionnaire for daily registration of symptoms of premenstrual syndrome taken from diagnostic and statistical manual of mental disorders.;The severity of symptoms of premenstrual syndrome with the degree of "none, mild, moderate and severe" and scoring from 0 to 3, the research units are divided into four groups: zero (absence of symptoms), mild (scores below 33%), moderate (-34 66%) and severe (above 66%) are divided. Timepoint: 2 and 4 months after the start of the study. Method of measurement: Questionnaire for daily registration of premenstrual syndrome symptoms taken from the diagnostic and statistical manual of mental disorders 5. | — |
Secondary
| Measure | Time frame |
|---|---|
| Possible side effects of the drug. Timepoint: During the 2 months of intervention. Method of measurement: Questionnaire of possible drug side effects. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFateme Mikaeilou
Shahid Beheshti University of Medical Sciences
Outcome results
None listed